Search

Your search keyword '"Perales C"' showing total 429 results

Search Constraints

Start Over You searched for: Author "Perales C" Remove constraint Author: "Perales C"
429 results on '"Perales C"'

Search Results

201. Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.

202. Synergistic Effects of Co 3 O 4 -gC 3 N 4 -Coated ZnO Nanoparticles: A Novel Approach for Enhanced Photocatalytic Degradation of Ciprofloxacin and Hydrogen Evolution via Water Splitting.

203. Fluoride anodic films on stainless-steel fomites to reduce transmission infections.

204. Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.

205. Viruses as archaeological tools for uncovering ancient molecular relationships.

206. Valorisation of Zingiber officinale Roscoe postharvest residues as byproducts with antioxidant capacity.

207. Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing.

209. Fitness-Dependent, Mild Mutagenic Activity of Sofosbuvir for Hepatitis C Virus.

210. Evaluation of Three Vaccination Schemes Against Clostridium perfringens Alpha Toxin and Their Effects on the Performance, Level of Intestinal Lesions, and Serum Antibody Titers in Broilers.

211. Evaluation of antioxidant capacity, structure, and surface morphology of ginger ( Zingiber officinale ) using different extraction methods.

212. Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells.

213. [Anti-smoking intervention in the acute phase of acute coronary syndrome: Is there additional benefit in patients included in a cardiac rehabilitation program?]

214. Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin.

215. Effects of fat sources on liver characteristics and intestinal morphometry in an early-life animal model.

216. Viral Fitness, Population Complexity, Host Interactions, and Resistance to Antiviral Agents.

217. Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient.

218. Efficacy decrease of antiviral agents when administered to ongoing hepatitis C virus infections in cell culture.

219. Cardiac Magnetic Resonance and Ventricular Arrhythmia Risk Assessment in Chronic Ischemic Cardiomyopathy: An Unmet Need?

220. SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations.

222. Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron.

223. SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes.

224. In vitro Selection of High Affinity DNA and RNA Aptamers that Detect Hepatitis C Virus Core Protein of Genotypes 1 to 4 and Inhibit Virus Production in Cell Culture.

225. Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools.

226. Application of archaeological concepts to the interpretation of RNA virus quasi species evolution.

227. A Two-Level, Intramutant Spectrum Haplotype Profile of Hepatitis C Virus Revealed by Self-Organized Maps.

228. Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients.

229. Akt Phosphorylation of Hepatitis C Virus NS5B Regulates Polymerase Activity and Hepatitis C Virus Infection.

230. Historical Perspective on the Discovery of the Quasispecies Concept.

231. Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics.

232. High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease.

233. Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.

234. Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus.

235. The time for COVID-19 vaccination.

236. Clinical Prediction Tool to Assess the Likelihood of a Positive SARS-Cov-2 (COVID-19) Polymerase Chain Reaction Test in Patients with Flu-like Symptoms.

237. Amino Acid Substitutions Associated with Treatment Failure for Hepatitis C Virus Infection.

238. A new implication of quasispecies dynamics: Broad virus diversification in absence of external perturbations.

239. Quasispecies dynamics and clinical significance of hepatitis C virus (HCV) antiviral resistance.

241. Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment.

242. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

243. Viral quasispecies.

244. [Effect of Solanum Tuberosum peel or pulp on organ weight and hepatic oxidative stress in obese rats].

245. Synergistic lethal mutagenesis of hepatitis C virus.

246. The increasing impact of lethal mutagenesis of viruses.

247. The archaeology of coding RNA.

248. Extracellular vesicles: Vehicles of en bloc viral transmission.

249. Viral fitness: history and relevance for viral pathogenesis and antiviral interventions.

250. Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.

Catalog

Books, media, physical & digital resources